摘要
细胞保护剂已成为抗肿瘤药物研究与开发领域的"新星",氨磷汀就是其中的一名佼佼者,在抗肿瘤、逆转耐药和保护正常细胞方面具有潜在的应用价值,目前已被广泛用于临床多种血液系统疾病。
Cell protective agents have become a new star in R&D of antineoplastic agents,and amifostine is one of the leaders with potential antineoplastic,tolerance-reversing,and normal cell protecting values,which has been widely used in a variety of blood system diseases in clinical practices.
出处
《中国处方药》
2010年第10期50-53,共4页
Journal of China Prescription Drug